Cyanidin suppresses autophagic activity regulating chondrocyte hypertrophic differentiation

J Cell Physiol. 2018 Mar;233(3):2332-2342. doi: 10.1002/jcp.26105. Epub 2017 Aug 25.

Abstract

Cartilage is a kind of special connective tissue which does not contain neither blood vessels nor lymphatics and nerves. Therefore, the damage in cartilage is difficult to be repaired spontaneously. Constructing tissue engineered cartilage provides a new technique for cartilage repairing. Mesenchymal stem cells (MSCs) possess a unique capability of self-renew and can differentiate into pre-chondrocytes which are frequently applied as seed cells in tissue engineering. However, in regenerated cartilage the chondrocytes derived from MSCs can hardly maintain homeostasis and preferentially present hypertrophic like phenotype. We investigated the effects of cyanidin, a natural organic compound, on chondrogenic and subsequent hypertrophic differentiation of MSCs in order to seek approaches to inhibit chondrocyte hypertrophy. We evaluated the effects of cyanidin on expression of chondrogenic and hypertrophic marker genes through RT-PCR, Western blot, alcian blue staining, and immunocytochemistry. The results showed that both chondrogenic related genes Sox9, Col2a1, and hypertrophic marker genes Runx2, Col10a1 were inhibited by cyanidin. In addition, we found that cyanidin promoted Nrf2 and p62 expression and suppressed LC3B expression during chondrogenic stage of MSCs. Meanwhile phosphorylation of IκBα and autophagosome related protein LC3B were inactivated by cyanidin during chondrocyte hypertrophic stage. Furthermore, rapamycin, an autophagy activator, abrogated the inhibitory effect of cyanidin on chondrogenic, and hypertrophic differentiation of MSCs. In conclusion, one potential mechanism of cyanidin, by which the chondrogenic and hypertrophic differentiation of MSCs were inhibited, was due to decreased autophagy activity. Our results indicated that cyanidin was a potential therapeutic agent for keeping mature chondrocyte functions.

Keywords: autophagy; chondrocyte hypertrophy; chondrogenic differentiation; cyanidin; mesenchymal stem cell.

MeSH terms

  • Animals
  • Anthocyanins / pharmacology*
  • Autophagosomes / drug effects
  • Autophagosomes / metabolism
  • Autophagosomes / pathology
  • Autophagy / drug effects*
  • Cell Differentiation / drug effects*
  • Cell Line
  • Chondrocytes / drug effects*
  • Chondrocytes / metabolism
  • Chondrocytes / pathology
  • Chondrogenesis / drug effects*
  • Collagen Type II / genetics
  • Collagen Type II / metabolism
  • Collagen Type X / genetics
  • Collagen Type X / metabolism
  • Core Binding Factor Alpha 1 Subunit / genetics
  • Core Binding Factor Alpha 1 Subunit / metabolism
  • Dose-Response Relationship, Drug
  • Gene Expression Regulation
  • Glycosaminoglycans / metabolism
  • Hypertrophy
  • Mesenchymal Stem Cells / drug effects*
  • Mesenchymal Stem Cells / metabolism
  • Mesenchymal Stem Cells / pathology
  • Mice, Inbred C3H
  • Microtubule-Associated Proteins / genetics
  • Microtubule-Associated Proteins / metabolism
  • NF-E2-Related Factor 2 / genetics
  • NF-E2-Related Factor 2 / metabolism
  • NF-KappaB Inhibitor alpha / metabolism
  • Phosphorylation
  • SOX9 Transcription Factor / genetics
  • SOX9 Transcription Factor / metabolism
  • Sequestosome-1 Protein / genetics
  • Sequestosome-1 Protein / metabolism
  • Signal Transduction / drug effects
  • Sirolimus / pharmacology
  • Time Factors

Substances

  • Anthocyanins
  • Col10a1 protein, mouse
  • Col2a1 protein, mouse
  • Collagen Type II
  • Collagen Type X
  • Core Binding Factor Alpha 1 Subunit
  • Glycosaminoglycans
  • Map1lc3b protein, mouse
  • Microtubule-Associated Proteins
  • NF-E2-Related Factor 2
  • Nfe2l2 protein, mouse
  • Nfkbia protein, mouse
  • Runx2 protein, mouse
  • SOX9 Transcription Factor
  • Sequestosome-1 Protein
  • Sox9 protein, mouse
  • Sqstm1 protein, mouse
  • NF-KappaB Inhibitor alpha
  • cyanidin
  • Sirolimus